Literature DB >> 9338791

Structure at 1.65 A of RhoA and its GTPase-activating protein in complex with a transition-state analogue.

K Rittinger1, P A Walker, J F Eccleston, S J Smerdon, S J Gamblin.   

Abstract

Small G proteins of the Rho family, which includes Rho, Rac and Cdc42Hs, regulate phosphorylation pathways that control a range of biological functions including cytoskeleton formation and cell proliferation. They operate as molecular switches, cycling between the biologically active GTP-bound form and the inactive GDP-bound state. Their rate of hydrolysis of GTP to GDP by virtue of their intrinsic GTPase activity is slow, but can be accelerated by up to 10(5)-fold through interaction with rhoGAP, a GTPase-activating protein that stimulates Rho-family proteins. As such, rhoGAP plays a crucial role in regulating Rho-mediated signalling pathways. Here we report the crystal structure of RhoA and rhoGAP complexed with the transition-state analogue GDP.AlF4- at 1.65 A resolution. There is a rotation of 20 degrees between the Rho and rhoGAP proteins in this complex when compared with the ground-state complex Cdc42Hs.GMPPNP/rhoGAP, in which Cdc42Hs is bound to the non-hydrolysable GTP analogue GMPPNP. Consequently, in the transition state complex but not in the ground state, the rhoGAP domain contributes a residue, Arg85(GAP) directly into the active site of the G protein. We propose that this residue acts to stabilize the transition state of the GTPase reaction. RhoGAP also appears to function by stabilizing several regions of RhoA that are important in signalling the hydrolysis of GTP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338791     DOI: 10.1038/39651

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  112 in total

1.  Crystal structures of Mycobacterium tuberculosis RecA and its complex with ADP-AlF(4): implications for decreased ATPase activity and molecular aggregation.

Authors:  S Datta; M M Prabu; M B Vaze; N Ganesh; N R Chandra; K Muniyappa; M Vijayan
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

2.  RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation.

Authors:  M K Pastey; J E Crowe; B S Graham
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 3.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

4.  Arabidopsis RopGAPs are a novel family of rho GTPase-activating proteins that require the Cdc42/Rac-interactive binding motif for rop-specific GTPase stimulation.

Authors:  G Wu; H Li; Z Yang
Journal:  Plant Physiol       Date:  2000-12       Impact factor: 8.340

5.  Crystal structure of the GAP domain of Gyp1p: first insights into interaction with Ypt/Rab proteins.

Authors:  A Rak; R Fedorov; K Alexandrov; S Albert; R S Goody; D Gallwitz; A J Scheidig
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

6.  Induced nucleotide specificity in a GTPase.

Authors:  Shu-ou Shan; Peter Walter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-27       Impact factor: 11.205

7.  Dimerization and its role in GMP formation by human guanylate binding proteins.

Authors:  Nazish Abdullah; Meena Balakumari; Apurba Kumar Sau
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

8.  Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2.

Authors:  U S Singh; M T Kunar; Y L Kao; K M Baker
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 9.  Biological phosphoryl-transfer reactions: understanding mechanism and catalysis.

Authors:  Jonathan K Lassila; Jesse G Zalatan; Daniel Herschlag
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

10.  A vascular cell-restricted RhoGAP, p73RhoGAP, is a key regulator of angiogenesis.

Authors:  Zhi-Jian Su; Christopher N Hahn; Gregory J Goodall; Niamh M Reck; Annabell F Leske; Ann Davy; Gabriel Kremmidiotis; Mathew A Vadas; Jennifer R Gamble
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.